Multiple Manufacturers

Cyclophosphamide

Manufacturer:

Multiple Manufacturers

Cyclophosphamide HCPCS:

J9070

HCPCS Code Descriptor:

Cyclophosphamide, 100 mg

Category:

J Code

Cyclophosphamide NDCs:

70860-0218-10, 68001-0565-28, 10019-0957-01, 50742-0521-10, 68001-0444-32, 16714-0858-01, 70121-1240-01, 00781-3255-94, 10019-0937-01, 10019-0942-01, 10019-0945-01, 70860-0218-05, 50742-0520-05, 68001-0443-27, 68001-0564-22, 10019-0956-01, 16714-0857-01, 72603-0326-01, 70121-1239-01, 00781-3244-94, 72572-0083-01, 10019-0936-01, 10019-0939-01, 10019-0944-01, 68001-0442-26, 70860-0218-03, 50742-0519-02, 10019-0955-01, 72603-0104-01, 16714-0859-01, 70121-1238-01, 00781-3233-94, 72572-0085-01, 10019-0935-01, 10019-0938-01, 10019-0943-01, 72572-0087-01

Primary Type:

Oncology

Generic/Specialty Status:

Multi-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

70860-0218-10, 70860-0218-05, 70860-0218-03

About Cyclophosphamide:

Cyclophosphamide is an Oncology drug manufactured by Athenex Pharmaceuticals and administered via the Intravenous route of administration. The J Code: J9070 is aligned to the drug Cyclophosphamide.

ACCESS PRICING AND MORE BY REGISTERING

J9070 Added Date:

January 1, 1984

J9070 Effective Date:

January 1, 1997

J9070 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Cyclophosphamide billing and coding information.
Our team did not identify a source for Cyclophosphamide patient assistance information. Please reach out to our team if you feel that this is a mistake.
Cyclophosphamide prescribing information can be found at the link below:
Information regarding Cyclophosphamide’s side effects can be found at MedlinePlus